Naltrexone Kit
Product Images NDC 69238-2794

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naltrexone (NDC 69238-2794). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Naltrexone For Extended Release Injectable Suspens 1)

Figure A (Naltrexone For Extended Release Injectable Suspens 1)
The text provides details about the contents of a Naltrexone for Extended-Release Injectable Suspension package. It includes a package insert, medication guide, diluent, vial containing Naltrexone microspheres, prepackaged syringe, and administration needles with clear needle protection devices. The text also mentions the types of needles included in the pack for preparation and administration.*
FDA Label Image

Figure J (Naltrexone For Extended Release Injectable Suspens 10)

Figure J (Naltrexone For Extended Release Injectable Suspens 10)
FDA Label Image

Structural Formula (Naltrexone For Extended Release Injectable Suspens 11)

Structural Formula (Naltrexone For Extended Release Injectable Suspens 11)
FDA Label Image

Figure 1 (Naltrexone For Extended Release Injectable Suspens 12)

Figure 1 (Naltrexone For Extended Release Injectable Suspens 12)
This text provides data on the percentage of patients who used Naltrexone for extended-release injectable suspension, with a sample size of 126 individuals. It also includes information on the percentage of opioid-free weeks for the patients.*
FDA Label Image

Carton (Naltrexone For Extended Release Injectable Suspens 13)

Carton (Naltrexone For Extended Release Injectable Suspens 13)
FDA Label Image

Figure B (Naltrexone For Extended Release Injectable Suspens 2)

Figure B (Naltrexone For Extended Release Injectable Suspens 2)
FDA Label Image

Figure C (Naltrexone For Extended Release Injectable Suspens 3)

Figure C (Naltrexone For Extended Release Injectable Suspens 3)
FDA Label Image

Figure D (Naltrexone For Extended Release Injectable Suspens 4)

Figure D (Naltrexone For Extended Release Injectable Suspens 4)
FDA Label Image

Figure E (Naltrexone For Extended Release Injectable Suspens 5)

Figure E (Naltrexone For Extended Release Injectable Suspens 5)
FDA Label Image

Figure F (Naltrexone For Extended Release Injectable Suspens 6)

Figure F (Naltrexone For Extended Release Injectable Suspens 6)
FDA Label Image

Figure G (Naltrexone For Extended Release Injectable Suspens 7)

Figure G (Naltrexone For Extended Release Injectable Suspens 7)
FDA Label Image

Figure H (Naltrexone For Extended Release Injectable Suspens 8)

Figure H (Naltrexone For Extended Release Injectable Suspens 8)
FDA Label Image

Figure I (Naltrexone For Extended Release Injectable Suspens 9)

Figure I (Naltrexone For Extended Release Injectable Suspens 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.